应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FATE Fate Therapeutics Inc
休市中 11-22 16:00:00 EST
2.29
+0.22
+10.63%
盘后
2.27
-0.02
-0.87%
19:37 EST
最高
2.36
最低
2.07
成交量
391.17万
今开
2.10
昨收
2.07
日振幅
14.01%
总市值
2.61亿
流通市值
2.26亿
总股本
1.14亿
成交额
890.09万
换手率
3.96%
流通股本
9,879万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Fate Therapeutics, Inc.盘中异动 股价大涨5.07%报2.18美元
市场透视 · 11-22 22:51
Fate Therapeutics, Inc.盘中异动 股价大涨5.07%报2.18美元
Fate Therapeutics, Inc.盘中异动 股价大涨5.96%
市场透视 · 11-20 22:56
Fate Therapeutics, Inc.盘中异动 股价大涨5.96%
Fate Therapeutics, Inc.盘中异动 急速下跌5.73%报2.14美元
市场透视 · 11-19
Fate Therapeutics, Inc.盘中异动 急速下跌5.73%报2.14美元
Fate Therapeutics, Inc.2024财年第三财季实现净利润-47.68百万美元,同比减少5.56%
市场透视 · 11-19
Fate Therapeutics, Inc.2024财年第三财季实现净利润-47.68百万美元,同比减少5.56%
Fate Therapeutics, Inc.盘中异动 股价大涨11.88%报2.26美元
市场透视 · 11-18
Fate Therapeutics, Inc.盘中异动 股价大涨11.88%报2.26美元
Fate Therapeutics, Inc.盘中异动 股价大跌5.05%
市场透视 · 11-15
Fate Therapeutics, Inc.盘中异动 股价大跌5.05%
Fate Therapeutics, Inc.盘中异动 股价大跌5.08%
市场透视 · 11-12
Fate Therapeutics, Inc.盘中异动 股价大跌5.08%
Fate Therapeutics, Inc.盘中异动 临近收盘股价大涨5.17%
市场透视 · 11-12
Fate Therapeutics, Inc.盘中异动 临近收盘股价大涨5.17%
Fate Therapeutics, Inc.盘中异动 早盘股价大跌5.10%
市场透视 · 11-08
Fate Therapeutics, Inc.盘中异动 早盘股价大跌5.10%
Fate Therapeutics, Inc.盘中异动 早盘急速下跌5.02%
市场透视 · 11-07
Fate Therapeutics, Inc.盘中异动 早盘急速下跌5.02%
Fate Therapeutics, Inc.盘中异动 股价大涨5.14%报2.56美元
市场透视 · 11-05
Fate Therapeutics, Inc.盘中异动 股价大涨5.14%报2.56美元
Fate Therapeutics, Inc.盘中异动 股价大跌5.02%报2.37美元
市场透视 · 11-01
Fate Therapeutics, Inc.盘中异动 股价大跌5.02%报2.37美元
Fate Therapeutics, Inc.盘中异动 早盘股价大涨5.09%
市场透视 · 10-28
Fate Therapeutics, Inc.盘中异动 早盘股价大涨5.09%
Fate Therapeutics, Inc.盘中异动 下午盘大幅跳水5.16%
市场透视 · 10-26
Fate Therapeutics, Inc.盘中异动 下午盘大幅跳水5.16%
Fate Therapeutics, Inc.盘中异动 快速跳水5.02%
市场透视 · 10-24
Fate Therapeutics, Inc.盘中异动 快速跳水5.02%
Fate Therapeutics, Inc.盘中异动 急速拉升5.08%报3.21美元
市场透视 · 10-17
Fate Therapeutics, Inc.盘中异动 急速拉升5.08%报3.21美元
Fate Therapeutics, Inc.盘中异动 早盘股价大跌5.00%
市场透视 · 10-07
Fate Therapeutics, Inc.盘中异动 早盘股价大跌5.00%
Fate Therapeutics, Inc.盘中异动 股价大涨5.13%
市场透视 · 10-04
Fate Therapeutics, Inc.盘中异动 股价大涨5.13%
Fate Therapeutics, Inc.盘中异动 快速跳水5.00%
市场透视 · 10-01
Fate Therapeutics, Inc.盘中异动 快速跳水5.00%
Fate Therapeutics, Inc.盘中异动 早盘快速上涨5.04%
市场透视 · 09-30
Fate Therapeutics, Inc.盘中异动 早盘快速上涨5.04%
加载更多
公司概况
公司名称:
Fate Therapeutics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fate Therapeutics, Inc.于2007年4月27日在特拉华州合并,是一家临床分期生物制药公司,致力于成体干细胞治疗调节器的探索与开发,治疗罕见疾病,包括一些恶性血液病、溶酶体贮积症和肌肉营养不良。Fate使用的一些新方法采用已有的治疗模式,包括小分子和治疗性蛋白,并瞄准良好的生物机制,以增强成体干细胞的疗效。
发行价格:
--
{"stockData":{"symbol":"FATE","market":"US","secType":"STK","nameCN":"Fate Therapeutics Inc","latestPrice":2.29,"timestamp":1732309200000,"preClose":2.07,"halted":0,"volume":3911677,"hourTrading":{"tag":"盘后","latestPrice":2.27,"preClose":2.29,"latestTime":"19:37 EST","volume":304533,"amount":697363.3792,"timestamp":1732322268599},"delay":0,"floatShares":98789051,"shares":113894333,"eps":-1.641185,"marketStatus":"休市中","marketStatusCode":7,"change":0.22,"latestTime":"11-22 16:00:00 EST","open":2.1,"high":2.36,"low":2.07,"amount":8900936.5212768,"amplitude":0.140097,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.641185,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1380600000000,"adjPreClose":2.07,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.22,"preClose":2.07,"latestTime":"08:35 EST","volume":7742,"amount":16700.4098786,"timestamp":1732282519505},"postHourTrading":{"tag":"盘后","latestPrice":2.27,"preClose":2.29,"latestTime":"19:37 EST","volume":304533,"amount":697363.3792,"timestamp":1732322268599},"volumeRatio":0.552486,"impliedVol":1.1681,"impliedVolPercentile":0.3929},"requestUrl":"/m/hq/s/FATE","defaultTab":"news","newsList":[{"id":"2485262353","title":"Fate Therapeutics, Inc.盘中异动 股价大涨5.07%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485262353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485262353?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:51","pubTimestamp":1732287085,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时51分,Fate Therapeutics, Inc.股票出现异动,股价急速上涨5.07%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.60%。其相关个股中,Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Virpax Pharmaceuticals, Inc.、Replimune Group, Inc.涨幅较大,Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃,换手率分别为1156.85%、87.89%、73.76%,振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为48.21%、33.24%、33.00%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122225125abd79b28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122225125abd79b28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4139"],"gpt_icon":0},{"id":"2484437641","title":"Fate Therapeutics, Inc.盘中异动 股价大涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484437641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484437641?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:56","pubTimestamp":1732114578,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时56分,Fate Therapeutics, Inc.股票出现异动,股价急速拉升5.96%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.24%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Silexion Therapeutics Corp涨幅较大,Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为918.31%、416.19%、161.31%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为163.37%、102.78%、65.87%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120225618971a7b41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120225618971a7b41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FATE","LENZ"],"gpt_icon":0},{"id":"2484284979","title":"Fate Therapeutics, Inc.盘中异动 急速下跌5.73%报2.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484284979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484284979?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:35","pubTimestamp":1732026918,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时35分,Fate Therapeutics, Inc.股票出现异动,股价快速下挫5.73%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.68%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Exicure, Inc.涨幅较大,Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃,换手率分别为642.15%、80.40%、65.78%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tff Pharmaceuticals, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ,振幅分别为52.14%、32.55%、28.79%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223518971a76c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223518971a76c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FATE","LENZ"],"gpt_icon":0},{"id":"2484915337","title":"Fate Therapeutics, Inc.2024财年第三财季实现净利润-47.68百万美元,同比减少5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484915337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484915337?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010422,"startTime":"0","endTime":"0","summary":"11月19日,Fate Therapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-47.68百万美元,同比减少5.56%;其中营业收入为3.07百万美元,同比增加58.25%,每股基本收益为-0.40美元。机构评级:截至2024年11月19日,当前有12家机构对Fate Therapeutics, Inc.目标价做出预测,其中目标均价为6.33美元,其中最低目标价为3.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180049abcedf10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180049abcedf10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE"],"gpt_icon":0},{"id":"2484766006","title":"Fate Therapeutics, Inc.盘中异动 股价大涨11.88%报2.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484766006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484766006?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940276,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分,Fate Therapeutics, Inc.股票出现异动,股价快速拉升11.88%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.22%。其相关个股中,Hcw Biologics Inc.、冠科美博、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃,换手率分别为514.50%、179.22%、175.30%,振幅较大的相关个股有Sage Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Innate Pharma,振幅分别为99.80%、11.85%、10.42%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822311695be4815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822311695be4815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FATE"],"gpt_icon":0},{"id":"2483308074","title":"Fate Therapeutics, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483308074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483308074?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:12","pubTimestamp":1731683541,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时12分,Fate Therapeutics, Inc.股票出现异动,股价大幅下跌5.05%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.88%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大,Tc Biopharm Plc、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为3022.08%、388.00%、274.15%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Celularity Inc C/Wts 16/07/2026 ,振幅分别为125.68%、114.92%、110.59%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115231221971a6e04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115231221971a6e04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FATE"],"gpt_icon":0},{"id":"2482269085","title":"Fate Therapeutics, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482269085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482269085?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:43","pubTimestamp":1731422616,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时43分,Fate Therapeutics, Inc.股票出现异动,股价大幅跳水5.08%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Geovax Labs, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为135.22%、125.68%、57.09%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Heron Therapeutics, Inc.,振幅分别为49.39%、34.55%、24.46%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112224336971a604d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112224336971a604d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4139"],"gpt_icon":0},{"id":"2482768477","title":"Fate Therapeutics, Inc.盘中异动 临近收盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482768477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482768477?lang=zh_cn&edition=full","pubTime":"2024-11-12 04:35","pubTimestamp":1731357319,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日04时35分,Fate Therapeutics, Inc.股票出现波动,股价快速上涨5.17%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.90%。其相关个股中,Cero Therapeutics Holdings, Inc.、Geovax Labs, Inc.、Aligos Therapeutics, Inc.涨幅较大,Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Geovax Labs, Inc.较为活跃,换手率分别为911.81%、521.44%、326.25%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Geovax Labs Inc C/Wts 29/09/2025,振幅分别为132.14%、72.42%、65.93%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111204351998e41e0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111204351998e41e0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FATE"],"gpt_icon":0},{"id":"2481369100","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481369100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481369100?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:20","pubTimestamp":1731079246,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时20分,Fate Therapeutics, Inc.股票出现异动,股价大幅跳水5.10%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.涨幅较大,Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃,换手率分别为562.19%、48.41%、42.39%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为86.00%、40.00%、31.72%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108232047a224e081&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108232047a224e081&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE","BK4139"],"gpt_icon":0},{"id":"2481182976","title":"Fate Therapeutics, Inc.盘中异动 早盘急速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481182976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481182976?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:12","pubTimestamp":1730992357,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时12分,Fate Therapeutics, Inc.股票出现异动,股价急速下挫5.02%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。其相关个股中,Ensysce Biosciences, Inc.、Celularity Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大,Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为573.02%、112.53%、89.31%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.、Celularity Inc.,振幅分别为68.89%、57.79%、35.86%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723123798e413a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723123798e413a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FATE","LENZ"],"gpt_icon":0},{"id":"2481254532","title":"Fate Therapeutics, Inc.盘中异动 股价大涨5.14%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481254532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481254532?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:45","pubTimestamp":1730742336,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时45分,Fate Therapeutics, Inc.股票出现波动,股价快速拉升5.14%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大,Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃,换手率分别为378.27%、275.62%、79.78%,振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Neurogene Inc.,振幅分别为52.25%、45.39%、39.98%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105014537a2159c7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105014537a2159c7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4139"],"gpt_icon":0},{"id":"2480058617","title":"Fate Therapeutics, Inc.盘中异动 股价大跌5.02%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480058617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480058617?lang=zh_cn&edition=full","pubTime":"2024-11-01 00:04","pubTimestamp":1730390646,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日00时04分,Fate Therapeutics, Inc.股票出现异动,股价快速跳水5.02%。截至发稿,该股报2.37美元/股,成交量34.1853万股,换手率0.30%,振幅5.22%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为3.46%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101000406a202d2f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101000406a202d2f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FATE","LENZ"],"gpt_icon":0},{"id":"2478650481","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478650481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478650481?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:48","pubTimestamp":1730123324,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时48分,Fate Therapeutics, Inc.股票出现异动,股价快速拉升5.09%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Tc Biopharm Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃,换手率分别为573.38%、50.78%、38.84%,振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Monopar Therapeutics Inc.、Monte Rosa Therapeutics, Inc.,振幅分别为45.41%、28.94%、23.31%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214844a1f256a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214844a1f256a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE","BK4139"],"gpt_icon":0},{"id":"2478957235","title":"Fate Therapeutics, Inc.盘中异动 下午盘大幅跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478957235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478957235?lang=zh_cn&edition=full","pubTime":"2024-10-26 02:09","pubTimestamp":1729879787,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日02时09分,Fate Therapeutics, Inc.股票出现波动,股价急速下跌5.16%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.57%。其相关个股中,Immunitybio, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Iterum Therapeutics Plc涨幅较大,180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃,换手率分别为849.80%、781.48%、366.13%,振幅较大的相关个股有Iterum Therapeutics Plc、Elevai Labs, Inc.、Qualigen Therapeutics, Inc.,振幅分别为102.56%、93.82%、91.58%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102602094798e3e8f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102602094798e3e8f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE","BK4139"],"gpt_icon":0},{"id":"2477557738","title":"Fate Therapeutics, Inc.盘中异动 快速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477557738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477557738?lang=zh_cn&edition=full","pubTime":"2024-10-24 02:03","pubTimestamp":1729706609,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日02时03分,Fate Therapeutics, Inc.股票出现波动,股价急速跳水5.02%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.40%。其相关个股中,Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Tevogen Bio Holdings Inc.涨幅较大,Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为1867.28%、1535.76%、508.44%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.,振幅分别为109.26%、71.86%、68.32%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024020330971a1dda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024020330971a1dda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE","BK4139"],"gpt_icon":0},{"id":"2476922124","title":"Fate Therapeutics, Inc.盘中异动 急速拉升5.08%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476922124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476922124?lang=zh_cn&edition=full","pubTime":"2024-10-17 03:31","pubTimestamp":1729107106,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日03时31分,Fate Therapeutics, Inc.股票出现波动,股价急速上涨5.08%。截至发稿,该股报3.21美元/股,成交量97.3939万股,换手率0.86%,振幅7.05%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.60%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017033146971a0b07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017033146971a0b07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE","BK4139"],"gpt_icon":0},{"id":"2473109884","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473109884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473109884?lang=zh_cn&edition=full","pubTime":"2024-10-07 22:03","pubTimestamp":1728309826,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日22时03分,Fate Therapeutics, Inc.股票出现异动,股价大幅下跌5.00%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Nutriband Inc C/Wts 涨幅较大,Aditxt, Inc.、Phio Pharmaceuticals Corp.、Scholar Rock Holding Corporation较为活跃,换手率分别为1035.08%、49.86%、24.10%,振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Aditxt, Inc.,振幅分别为83.83%、39.46%、30.62%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007220347a1dead69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007220347a1dead69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FATE"],"gpt_icon":0},{"id":"2472954747","title":"Fate Therapeutics, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472954747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472954747?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:31","pubTimestamp":1728048683,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时31分,Fate Therapeutics, Inc.股票出现异动,股价大幅拉升5.13%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。其相关个股中,Aditxt, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大,Aditxt, Inc.、Elevai Labs, Inc.、Theriva Biologics, Inc.较为活跃,换手率分别为1359.03%、15.89%、13.56%,振幅较大的相关个股有Estrella Immunopharma, Inc.、Theriva Biologics, Inc.、Promis Neurosciences Inc.,振幅分别为9.01%、7.26%、7.21%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100421312498e3a944&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100421312498e3a944&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4139"],"gpt_icon":0},{"id":"2472137142","title":"Fate Therapeutics, Inc.盘中异动 快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472137142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472137142?lang=zh_cn&edition=full","pubTime":"2024-10-01 22:14","pubTimestamp":1727792095,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日22时14分,Fate Therapeutics, Inc.股票出现异动,股价快速跳水5.00%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.28%。其相关个股中,Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Aditxt, Inc.、Silexion Therapeutics Corp、Sagimet Biosciences Inc. - Series A较为活跃,换手率分别为600.82%、541.25%、103.30%,振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tc Biopharm Plc C/Wts 10/02/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ,振幅分别为97.67%、82.42%、48.90%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100122145598e39f60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100122145598e39f60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FATE","BK4139"],"gpt_icon":0},{"id":"2471338635","title":"Fate Therapeutics, Inc.盘中异动 早盘快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471338635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471338635?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:50","pubTimestamp":1727704214,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时50分,Fate Therapeutics, Inc.股票出现异动,股价快速上涨5.04%。Fate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,Kezar Life Sciences, Inc.、Prime Medicine, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大,Aditxt, Inc.、Seelos Therapeutics, Inc.、Onconetix, Inc.较为活跃,换手率分别为59.34%、23.37%、23.35%,振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Cingulate Inc C/Wts 10/12/2026 、Plus Therapeutics, Inc.,振幅分别为32.54%、31.55%、28.10%。Fate Therapeutics, Inc.公司简介:Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930215014ab672852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930215014ab672852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fatetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.1337},{"period":"1month","weight":-0.2442},{"period":"3month","weight":-0.4036},{"period":"6month","weight":-0.3494},{"period":"1year","weight":-0.0418},{"period":"ytd","weight":-0.3877}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fate Therapeutics, Inc.于2007年4月27日在特拉华州合并,是一家临床分期生物制药公司,致力于成体干细胞治疗调节器的探索与开发,治疗罕见疾病,包括一些恶性血液病、溶酶体贮积症和肌肉营养不良。Fate使用的一些新方法采用已有的治疗模式,包括小分子和治疗性蛋白,并瞄准良好的生物机制,以增强成体干细胞的疗效。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.058546},{"month":2,"riseRate":0.636364,"avgChangeRate":0.08272},{"month":3,"riseRate":0.545455,"avgChangeRate":0.019657},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.055265},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.016902},{"month":6,"riseRate":0.545455,"avgChangeRate":0.010259},{"month":7,"riseRate":0.454545,"avgChangeRate":0.056385},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.021881},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.018445},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.106424},{"month":11,"riseRate":0.5,"avgChangeRate":0.080419},{"month":12,"riseRate":0.636364,"avgChangeRate":0.109378}],"exchange":"NASDAQ","name":"Fate Therapeutics Inc","nameEN":"Fate Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fate Therapeutics Inc(FATE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fate Therapeutics Inc,FATE,Fate Therapeutics Inc股票,Fate Therapeutics Inc股票老虎,Fate Therapeutics Inc股票老虎国际,Fate Therapeutics Inc行情,Fate Therapeutics Inc股票行情,Fate Therapeutics Inc股价,Fate Therapeutics Inc股市,Fate Therapeutics Inc股票价格,Fate Therapeutics Inc股票交易,Fate Therapeutics Inc股票购买,Fate Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fate Therapeutics Inc(FATE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}